Sponsor pipeline

Marengo Therapeutics, Inc. clinical trial pipeline

Get alerts when Marengo Therapeutics, Inc.'s trials change

2 active trials 2 recruiting 4 disease areas 3 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-12
Primary completion pushed: 2026-10 → 2027-09
Trial sites reduced: 32 → 19 locations
Completion pushed: 2026-10 → 2027-09
NCT05592626 A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion… · Phase 1/2

Active trials by phase

Phase 1/2
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT05592626 A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion… Advanced Solid Tumors Recruiting 2026-08-11
NCT06827613 A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting… Triple Negative Locally Advanced Non-resectable Breast Cancer Recruiting 2025-09-24

Disease areas by active trials

Non-Small Cell Lung Cancer (NSCLC) (1) · Lung Cancer (1) · Colorectal Cancer (1) · Breast Cancer (1)

Get alerts when Marengo Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free